CJJ300 is a transforming growth factor-beta (TGF-beta) inhibitor with an IC50 of 5.3 µM. CJJ300 inhibits TGF-beta signaling by disrupting the formation of the TGF-beta-TbetaR-I-TbetaR-II signaling complex[1].
Molecular Weight:
435.60
Purity:
99.36
CAS Number:
[1807631-83-9]
Formula:
C30H33N3
Target:
TGF-beta Receptor
Application Notes:
Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted